[Indications for the eradication of Helicobacter pylori. Reflections on the Maastricht consensus conference].
Boixeda de Miquel
D
D
Servicio de Gastroenterología, Hospital Ramón y Cajal, Madrid.
Martín de Argila
C
C
Pérez Gisbert
J
J
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003245:Consensus Statements as Topic; D004381:Duodenal Ulcer / Q000188:drug therapy / Q000209:etiology; D004415:Dyspepsia / Q000188:drug therapy / Q000209:etiology; D005260:Female; D005756:Gastritis / Q000188:drug therapy / Q000209:etiology; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000209:etiology; D008297:Male; D009426:Netherlands; D012008:Recurrence; D012307:Risk Factors; D013274:Stomach Neoplasms / Q000209:etiology; D013276:Stomach Ulcer / Q000188:drug therapy / Q000209:etiology
D000894:Anti-Inflammatory Agents, Non-Steroidal